Research Article
Diagnostic Values of Laboratory Biomarkers in Predicting a Severe Course of COVID-19 on Hospital Admission
Table 2
Baseline demographics and clinical characteristics between mild, moderate, and severe groups of COVID-19 patients on admission.
| Demographic and clinical characteristics | Total () | | Mild (117) | Moderate (99) | Severe (134) | value |
| Age | | | | | 18-44 | 64.3% | 23.5% | 12.2% | 0.0001 | 45-59 | 30.5% | 27.6% | 41.9% | ≥60 | 15.6% | 30.5% | 53.9% | Gender | | | | | Male | 60.7% | 82.8% | 77.6% | 0.001 | Female | 39.3% | 16.2% | 21.6% | Comorbidities | | | | | Diabetes mellitus | 24 (15.1%) | 53 (33.3%) | 82 (51.6%) | 0.0001 | Hypertension | 24 (16%) | 49 (32.7%) | 77 (51.3%) | 0.0001 | CAD | 5 (8.6%) | 21 (36.2%) | 32 (55.2%) | 0.0001 | CKD | 0 | 6 (23.1%) | 20 (76.9%) | 0.0001 | Others | 26 (27.4%) | 29 (30.5%) | 40 (42.1%) | 0.027 | Clinical manifestations | | | | | Fever | 85 (34.8%) | 73 (30%) | 86 (35.2%) | 0.204 | Dry cough | 62 (33.3%) | 56 (30%) | 68 (37%) | 0.678 | Sore throat | 23(57.5%) | 15 (37.5%) | 2 (5%) | 0.0001 | Difficulty in breathing | 21 (14.4%) | 40 (27.4%) | 85 (58.2%) | 0.0001 | Vitals on admission | | | | | Pulse | | | | 0.0001 | Respiratory rate | | | | 0.0001 | Spo2 | | | | 0.0001 | Survivors | 117 (42.7%) | 88 (32.1%) | 69 (25.2%) | 0.0001 | Nonsurvivors | 0 | 11 (14.5%) | 65 (85.5%) | 0.0001 |
|
|
Data are represented as (%) or . The asterisk ( ) indicates statistical significance. |